CER Daily Newsfeed

Less Fatigue in Multiple Sclerosis With CBT and Modafinil

(11/13, Anushree Chaphalkar, Medscape) reports “Fatigue related to multiple sclerosis (MS) was significantly reduced following 12 weeks of treatment with cognitive behavioral therapy (CBT) and modafinil, either alone or in combination, a new study shows.” Full

Opinion: Don’t Import Bad Policy Ideas on Drug Pricing

(11/13, Kirsten Axelsen, BioSpace) comments “...Politicians who want to exert more government pricing power over medications compare the prices of drugs in other countries to the U.S. and complain about the unfairness of it. They don’t share what is lost in countries with centralized health systems, which often ration access to drugs, providing coverage only after a person has become very, very sick.” Full

Canada’s Data Linkage Roadmap To Drive Decision Making For Rare Disease Drugs

(11/13, Francesca Bruce, Pink Sheet) reports “...Canada’s Drug Agency has published a new roadmap that will facilitate linking disease and patient registries with administrative health services data with the goal of answering research and policy questions and informing decision making with regard to treating rare disease patients.” Subscription Required